536MO A phase I, first-in-human, safety, pharmacokinetic,...

Annals of Oncology 2020 / 09 Vol. 31

536MO A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumours

Adjei, A.A., Beg, M., Melear, J., Thompson, J., Tsai, F.Y-C., Baranda, J.C., Bastos, B., Spira, A., Lou, Y., Seetharam, M., Uemura, M., Camidge, D.R., Yamamoto, N., Cowey, C.L., Doi, T., Anthony, S.P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.650
Date:
September, 2020
File:
PDF, 77 KB
2020
Conversion to is in progress
Conversion to is failed